rdf:type |
|
lifeskim:mentions |
umls-concept:C0006142,
umls-concept:C0012171,
umls-concept:C0017262,
umls-concept:C0018270,
umls-concept:C0018284,
umls-concept:C0019929,
umls-concept:C0021246,
umls-concept:C0027651,
umls-concept:C0034693,
umls-concept:C0034721,
umls-concept:C0185117,
umls-concept:C0205251,
umls-concept:C0449438,
umls-concept:C1280500,
umls-concept:C2911684
|
pubmed:issue |
6
|
pubmed:dateCreated |
1993-8-12
|
pubmed:abstractText |
The effects of high and low dietary fat (20% vs. 0.5% corn oil), and of the prostaglandin synthetase inhibitor indomethacin (0.005% w/w), on tumour incidence, tumour growth, hormone-receptor status and growth-factor expression were examined in dimethylbenzanthracene (DMBA)-induced rat breast cancer. The high dietary-fat group showed a significantly higher tumour incidence, larger tumour size and larger number of bromodeoxyuridine(BrdU)-positive cells of tumours as compared with those in the low dietary-fat group. Indomethacin reduced tumour incidence significantly, but conversely increased the tumour size and the number of BrdU-positive cells in both the high and the low dietary-fat groups. No significant difference was noted in the hormone-receptor status of the tumours. Growth factors (TGF-alpha and IGF-II) were somewhat highly expressed in the high dietary-fat group as compared with the low dietary-fat group, but indomethacin rather reduced the growth-factor expression. It is concluded that high dietary fat stimulates tumour incidence and tumour proliferation, while indomethacin has dual effects: a stimulating effect on tumour proliferation, but an inhibiting effect on tumour incidence. It is also suggested that hormone-receptor status and growth-factor expression do not play an important role in their stimulating effects on tumour proliferation.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/9,10-Dimethyl-1,2-benzanthracene,
http://linkedlifedata.com/resource/pubmed/chemical/Bromodeoxyuridine,
http://linkedlifedata.com/resource/pubmed/chemical/Dietary Fats, Unsaturated,
http://linkedlifedata.com/resource/pubmed/chemical/Growth Substances,
http://linkedlifedata.com/resource/pubmed/chemical/Indomethacin,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Estrogen,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Progesterone
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0250-0868
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
14
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
269-76
|
pubmed:dateRevised |
2003-11-14
|
pubmed:meshHeading |
pubmed-meshheading:1306527-9,10-Dimethyl-1,2-benzanthracene,
pubmed-meshheading:1306527-Animals,
pubmed-meshheading:1306527-Body Weight,
pubmed-meshheading:1306527-Bromodeoxyuridine,
pubmed-meshheading:1306527-Cell Division,
pubmed-meshheading:1306527-Dietary Fats, Unsaturated,
pubmed-meshheading:1306527-Female,
pubmed-meshheading:1306527-Growth Substances,
pubmed-meshheading:1306527-Immunohistochemistry,
pubmed-meshheading:1306527-Incidence,
pubmed-meshheading:1306527-Indomethacin,
pubmed-meshheading:1306527-Mammary Neoplasms, Experimental,
pubmed-meshheading:1306527-Rats,
pubmed-meshheading:1306527-Rats, Sprague-Dawley,
pubmed-meshheading:1306527-Receptors, Estrogen,
pubmed-meshheading:1306527-Receptors, Progesterone
|
pubmed:year |
1992
|
pubmed:articleTitle |
Effects of high and low dietary fat and indomethacin on tumour growth, hormone receptor status and growth factor expression in DMBA-induced rat breast cancer.
|
pubmed:affiliation |
Pathology Section, Kanazawa University Hospital, Japan.
|
pubmed:publicationType |
Journal Article
|